Literature DB >> 2099435

Peritoneal mesothelioma.

J H Anderson1, C J Stewart, D T Hansell, J R Anderson.   

Abstract

We report two patients who presented with small bowel obstruction secondary to peritoneal mesothelioma. The difficulties in establishing this diagnosis at an early stage are illustrated. Recent advances in the management of peritoneal mesothelioma are reviewed.

Entities:  

Mesh：

Year:  1990        PMID： 2099435      PMCID： PMC2429703          DOI： 10.1136/pgmj.66.780.866

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  12 in total

1.  PERITONEAL TUMOURS IN ASBESTOSIS.

Authors:  J B ENTICKNAP; W J SMITHER
Journal:  Br J Ind Med       Date:  1964-01

2.  Comparison of tumour markers in malignant mesothelioma and pulmonary adenocarcinoma.

Authors:  A R Gibbs; R Harach; J C Wagner; B Jasani
Journal:  Thorax       Date:  1985-02       Impact factor: 9.139

Review 3.  Peritoneal mesothelioma.

Authors:  C G Moertel
Journal:  Gastroenterology       Date:  1972-08       Impact factor: 22.682

4.  Incidence of mesothelioma in Britain.

Authors:  B Jones; P Thomas
Journal:  Lancet       Date:  1986-05-31       Impact factor: 79.321

5.  Further thoughts on the diagnosis and treatment of patients with macular degeneration.

Authors:  S L Fine
Journal:  Arch Ophthalmol       Date:  1983-08

6.  Diagnosis of peritoneal mesothelioma: computed tomography, sonography, and fine-needle aspiration biopsy.

Authors:  K Reuter; V Raptopoulos; F Reale; F J Krolikowski; C J D'Orsi; S Graham; E H Smith
Journal:  AJR Am J Roentgenol       Date:  1983-06       Impact factor: 3.959

7.  Early peritoneal mesothelioma: a treatable malignancy.

Authors:  K H Antman; R T Osteen; K L Klegar; D A Amato; E A Pomfret; D A Larson; J M Corson
Journal:  Lancet       Date:  1985-11-02       Impact factor: 79.321

8.  Mesothelioma in Scotland.

Authors:  J McEwen; A Finlayson; A Mair; A A Gibson
Journal:  Br Med J       Date:  1970-12-05

9.  Cisplatin administered by the intracavitary route as treatment for malignant mesothelioma.

Authors:  M Markman; S Cleary; C Pfeifle; S B Howell
Journal:  Cancer       Date:  1986-07-01       Impact factor: 6.860

10.  Peritoneal mesothelioma.

Authors:  M Kannerstein; J Churg
Journal:  Hum Pathol       Date:  1977-01       Impact factor: 3.466
View more
  1 in total

1.  Peritoneal mesothelioma: an unusual cause of an acute phase response presenting to the rheumatologist.

Authors:  S S Hamdulay; H T Cook; N Strickland; K A Davies; J C Mason
Journal:  Clin Rheumatol       Date:  2006-01-14       Impact factor: 2.980
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.